Immunosupressants and Modulators Flashcards

1
Q

phosphlipase (PLA2) in arachidonic acid synthesis

A

in charge of turning fatty acid from cell membrane into the arachidonic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

COX1/2 (cyclooxygenases) role on arachidonic acid

A

turns the acid into prostaglandins and thromboxanes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Lipoxygenases role on arachidonic acid

A

turns the acid into leukotrienes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

cytochrome p450 role on arachidonic acid

A

turns acid into epoxides and HETEs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Where are prostaglandins made?

A

made by most cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Where are thromboxanes made?

A

in platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Where are leukotrienes made?

A

in leukocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

NSAIDs mechanism of action

A

inhibit COX1/2 in arachidonic acid breakdown, so cells cannot make prostaglandins and thromboxanes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

COX1 role in body

A

constitutively expressed and in charge of homeostatic functions like renal, GI mucosal, and platelet function

inhibiting cox 1 will lead to more toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Cox-2 role in body

A

mainly in charge of the inflammatory response and is only selectively activated, so inhibitors of Cox2 are more effective in leading to a therapeutic effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

NSAIDs toxicity in the GI tract

A

leads to a decrease in mucosal secretions because of inhibition of the PGE2…sometimes can lead to gastric bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

PGE2 role in GI

A

is in charge of stimulating mucosal secretions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What can you coadminister to help the NSAIDs GI toxicity?

A

an antacid like prilosec may help avoid gastric bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

PGE2 role in kidney and toxicity with NSAIDs

A

It helps vasodilate in kidney and lead to filtration, since NSAIDs inhibit the production the vessels stay constricted and not enough is filtered and can lead to kidney damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Thromboxane A2 toxicity with NSAIDs

A

NSAIDs inhibit TXA2 which are in charge of promoting platelet activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Pharmacokinetics mechanism of aspirin

A

irreversibly binds COX1 through covalent modifications, so has longer lasting effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

When is aspirin used for ischemic conditions?

A

now only used as a medication following a stroke of MI, not suggested to give prior

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Random disease aspirin cures?

A

kawasaki disease

maybe colorectal cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Reyes syndrome

A

viral infection..then give aspirin..leads to disease with neurological effects and is very deadly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Aspirin and asthma interaction?

A

can have aspirin sensitive asthma due to blocking the COX pathway and forcing arachidonic acid down the leukotriene pathway and therefore make leukotrienes that lead to bronchoconstriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Two NSAIDs with extreme COX2 selectivity

A

Celebrex (celecoxib) and Vioxx (rofecoxib)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Problem with the COX2 selectivity drugs?

A

lead to less GI toxicity but way more cardiovascular toxicities, and inhibit PGI2 which is for anti-clotting factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Two Different mechanism for Leukotrienes inhibition?

A

can inhibit the lipoxygenase (LOX) or inhibit the leukotrienes themselves

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Luekotriene antagonist drug name

A

Montelukast

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Lipoxygenase (LOX) inhibitor drug name

A

Zileuton

26
Q

What do corticosteroids effect?

A

they block the production of prostaglandins, thromboxanes and leukotrienes

27
Q

Main types of corticosteroids…4

A

hydrocortisone, prednisone, mehtylprednisolone, Dexamethasone

28
Q

Mechanism of corticosteroids

A

pass through membranes because of hydrophobicit and then serve to effect transcription…mainly inhibit expression of inflammatory products like TNF and induce expression of anti inflammatory like lipocortin

29
Q

Lipocortin or Annexin 1 relation to corticosteroids

A

This is the antiinflammatory product that is induced by corticosteroids

30
Q

Lipocortin mechanism of antiinflammatory effect

A

inhibits the phospholipases PLA2 in eicosanoid production

31
Q

Corticosteroid toxicity in respiratory

A

CSs are mainly adminstered orally, leads to increased risk of thrush and pneumonia

32
Q

Corticosteroid toxicity examples

A

weight gain, moon face (CS redistributes fat), skin thinning, high BP, increased bone fracture risk

33
Q

What molecule makes corticosteroids weaken the skin?

A

Keratin

34
Q

What molecule makes corticosteroids lead to increas bone fracture risk?

A

osteocalcin

35
Q

Calcineurin inhibitors mechanism

A

calcineurin is downstream in the TCR complex, so inhibiting it means it is unlikely the T cell will make IL-2

36
Q

Common drugs that are calcineurin inhibitors

A

cyclosporin and tacrolimus

37
Q

Calcineurin inhibitor toxicities

A

malignancies…non hodgkins lymphoma most common

38
Q

Mechanism of JAK STAT inhibitors

A

Inhibits Jak3 and doesnt allow the cell IL-2 receptor cascade to occur, so no IL2/cytokine production

39
Q

JAK STAT inhibitor drug name

A

Tofacitinib

40
Q

cytokine antibody drugs mechanism

A

antibodies bind and inhibit the cytokines, especially TNF

41
Q

common cytokine antibody drug names

A

adalimumab
mepolizumab
tocilizumab

42
Q

Mepolizumab mechanism and use

A

binds to IL-5 and inhibits its action… which is mainly in eosinophils…some people have eosinophil asthma and this is effective in treating it

43
Q

Mechanism of DNA synthesis inhibitors

A

though different mechanisms, they all converge by not allowing production of purine nucelotides and therefore inhibit proliferation of T cells and other cells

44
Q

Azathioprine mechanisms (2)

A

can be similar in form to a adenine or guanine and be inserted into chain…leads to cell death

or

a form that simply blocks DNA synthesis without being inserted

45
Q

Azathioprine toxicity

A

if it is inserted and does not lead to cell death…can have mutagenecity

acute myeloid leukemia
lung adenocarcinoma

46
Q

3 important DNA/RNA synthesis inhibitors

A

azathioprine
mycophenolate
methotrexate

47
Q

mycophenolate mechanism of action

A

inhibits production of GTP which is needed for DNA/RNA synthesis

48
Q

methotrexate mechanism of action

A

inhibits the dihydro folate receptor which is involved with folate and production of purines for DNA

49
Q

can you give any DNA/RNA synthesis inhibitors when pregnant?

A

NO…do not give azathioprine or mycophenolate and definitely do not give methotrexate

50
Q

leflunomide mechanism of action and use

A

used for inhibiting tumors and inhibits production of WBCs

blocks production of nucleotide precursors

51
Q

mTOR inhibitor mechanism of action

A

mTOR is mammalian target of rapamycin which is in the IL-2R cascade and when inhibited does not allow cell proliferation in response to IL-2

52
Q

common drug for mTOR inhibitor

A

Sirolimus

53
Q

Common drugs for cytokine receptor antibodies

A
Anakinra
Basilixumab
Benzralizumab
Omalizumab
Rituximab
54
Q

Anakinra receptor and target cell

A

IL-1R, various

55
Q

Basilixumab receptor and target cell

A

IL-2R, T cells

56
Q

Benralizumab receptor and target cell

A

IL-5R, eosinophils

57
Q

Omalizumab receptor and target cell

A

IgE, B cells

58
Q

Rituximab receptor and target cell

A

CD20 and B cells

59
Q

how do you decrease absorption of drugs as you age?

A

decrease SA in intestines, decrease blood flow in GI tract

may want to consider increasing doses

60
Q

mechanisms of reducing metabolism of drugs as age?

A

decreased hepatic metabolism and biliary excretion

means you may want to reduce dosage

61
Q

mechanisms of changing distribution as age?

A

decrease albumin, decrease in lean body mass and total body water

may want to modify dosage

62
Q

Mycophenolate suggestion for decreased absorption in aging?

A

possibly increase dosage due to reduced GI blood flow and smaller SA in the SI